GENOME RESEARCH TRADING LIMITED

Active London

Other professional, scientific and technical activities n.e.c.

0 employees website.com
Other professional, scientific and technical activities n.e.c.
G

GENOME RESEARCH TRADING LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 11 Mar 2016 Active London, United Kingdom 0 employees website.com
Other professional, scientific and technical activities n.e.c.

Previous Company Names

WTSI TRADING LIMITED 11 Mar 2016 — 18 Oct 2016
Accounts Submitted 17 Feb 2026 Next due 30 Jun 2026 1 month remaining
Confirmation Submitted 27 Jan 2026 Next due 3 Feb 2027 8 months remaining
Net assets £1 £0 2025 year on year
Total assets £517K £25K 2025 year on year
Total Liabilities £517K £25K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Gibbs Building 215 Euston Road London NW1 2BE United Kingdom

Full company profile for GENOME RESEARCH TRADING LIMITED (10058101), an active company based in London, United Kingdom. Incorporated 11 Mar 2016. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2025
Type small
Next accounts 30 Sept 2025
Due by 30 Jun 2026 1 month remaining

Balance Sheet & P&L (2016–2025)

Cash in Bank

£232.38k

Decreased by £29.79k (-11%)

Net Assets

£1.00

Total Liabilities

£516.91k

Decreased by £24.61k (-5%)

Turnover

£2.07M

Decreased by £104.56k (-5%)

Employees

N/A

Debt Ratio

100%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Sept Year End
2024
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Jeffrey RyenDirectorAmericanEngland5913 Dec 2024Active

Shareholders

Shareholders (1)

Genome Research Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 8 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GENOME RESEARCH TRADING LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Feb 2026AccountsAnnual accounts made up to 30 Sept 2025
27 Jan 2026Confirmation StatementConfirmation statement made on 20 Jan 2026 with no updates
24 Jan 2025OfficersAppointment of Mr Simon David Moore as director on 24 Jan 2025
20 Jan 2025Confirmation StatementConfirmation statement made on 20 Jan 2025 with no updates
9 Jan 2025AccountsAnnual accounts made up to 30 Sept 2024
17 Feb 2026 Accounts

Annual accounts made up to 30 Sept 2025

27 Jan 2026 Confirmation Statement

Confirmation statement made on 20 Jan 2026 with no updates

24 Jan 2025 Officers

Appointment of Mr Simon David Moore as director on 24 Jan 2025

20 Jan 2025 Confirmation Statement

Confirmation statement made on 20 Jan 2025 with no updates

9 Jan 2025 Accounts

Annual accounts made up to 30 Sept 2024

Recent Activity

Latest Activity

Annual accounts made up to 30 Sept 2025

3 months ago on 17 Feb 2026

Confirmation statement made on 20 Jan 2026 with no updates

4 months ago on 27 Jan 2026

Appointment of Mr Simon David Moore as director on 24 Jan 2025

1 years ago on 24 Jan 2025

Confirmation statement made on 20 Jan 2025 with no updates

1 years ago on 20 Jan 2025

Annual accounts made up to 30 Sept 2024

1 years ago on 9 Jan 2025